Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Authors
Keywords
-
Journal
BLOOD
Volume 123, Issue 17, Pages 2645-2651
Publisher
American Society of Hematology
Online
2014-03-14
DOI
10.1182/blood-2014-02-553800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition
- (2013) A. G. Fleischman et al. BLOOD
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
- (2013) E. Such et al. BLOOD
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
- (2013) O Kosmider et al. LEUKEMIA
- CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
- (2013) A Pardanani et al. LEUKEMIA
- Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
- (2013) J Broséus et al. LEUKEMIA
- SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
- (2013) M Meggendorfer et al. LEUKEMIA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
- (2013) Julia E. Maxson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms
- (2012) S. Jeromin et al. HAEMATOLOGICA
- Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q)
- (2012) Julia Turbiner Geyer et al. HUMAN PATHOLOGY
- WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations
- (2010) M M Patnaik et al. LEUKEMIA
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes
- (2008) Matteo Giovanni Della Porta et al. JOURNAL OF CLINICAL ONCOLOGY
- The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
- (2008) A Orazi et al. LEUKEMIA
- Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm
- (2008) Falko Fend et al. LEUKEMIA RESEARCH
- Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification
- (2007) Laura Cannella et al. LEUKEMIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started